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ABSTRACT
One of the indicated elements of post-resuscitation care is therapeutic hypothermia or temperature treat-
ment management. the survivability of out-of-hospital cardiac arrest (OHCA) till admission to hospital is 
only 23%. Efficient thermoregulatory mechanisms are the basis for maintaining optimal body tempera-
ture. Therapeutic hypothermia shows normalizing effect on metabolic processes disturbed in ischaemic 
conditions, including improving metabolism and maintaining glucose balance in the brain, lowering the 
concentration of lactates, limiting the secretion of free radicals in damaged neurons, lowering the produc-
tion of pro-inflammatory cytokines, stabilizes the blood-brain barrier and reduces endothelial dysfunction 
preventing ischaemic damage to tissues and organs. Hypothermia has a wide multidirectional effect on the 
human body, which can be useful in patients. Most available scientific studies show the efficacy and benefits 
of hypothermia in patients with out-of-hospital sudden cardiac arrest, including especially with ventricular 
fibrillation. The delay in the initiation of therapeutic hypothermia and reaching target temperature signifi-
cantly increased the odds of a poor neurological outcome. Current American Heart Association (AHA) and 
European Resuscitation Council (ERC) resuscitation guidelines recommend that targeted temperature man-
agement should be implemented in all adult coma patients with return of spontaneous circulation (ROCS) 
after sudden cardiac arrest. The target temperature should be between 32°C and 36°C and then maintained 
for at least 24 hours. In patients with coma after TTM, fever should be actively prevented. For patients with 
out-of-hospital cardiac arrest, it is not recommended to routinely cool patients in prehospital conditions with 
a rapid intravenous infusion of cold fluids after ROSC. 
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InTRodUCTIon
In Europe, sudden cardiac arrest occurs with a rate 
of 0.4 to 1 per 1000 people per year, affecting 
between 350 000 and 700 000 people [1]. The 
Sasson et al. study showed that the survivability of 
out-of-hospital cardiac arrest (OHCA) until admis-
sion to hospital is only 23% [2]. The resuscitation 
procedure itself is only one part of the treatment 
of a patient with cardiac arrest. Rescue procedures 
do not end when spontaneous circulation returns, 
but also include time after ROSC and are designed 
to stabilize the patient’s condition and reduce or-
gan damage from long-term hypoxia and inflam-
mation. This can be confirmed by the guidelines of 
the American Heart Association, in which already in 
2010 a separate chapter on post-resuscitation care 
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was introduced [3]. One of the indicated elements 
of post-resuscitation care is therapeutic hypothermia 
or temperature treatment management. During the 
last decade, the introduction of mild therapeutic hy-
pothermia has been demonstrated to improve neu-
rological outcome and survival after out-of-hospital 
cardiac arrest due to ventricular fibrillation. 
Basics of thermoregulation
Thermoregulation is the ability to maintain a con-
stant body temperature regardless of the ambient 
temperature. Efficient thermoregulatory mecha-
nisms are the basis for maintaining optimal body 
temperature. The best-known thermoregulatory 
model is the two-factor thermal model developed 
by Gagge et al. [4]. It consists of two concentric 
cylinders: external, so-called shell (skin, adipose tis-
sue and muscles) with temperature in the range of 
28–35 °C, and internal, so-called cortex including 
the brain, abdominal organs and chest with a reg-
ulated temperature of about 37°C. In this system, 
the skin acts as a buffer between the body and the 
external environment and is dependent on the heat 
exchange between these areas. The temperature sig-
nal is transmitted via thermosensitive, cation-selec-
tive ion channels, the so-called instantaneous poten-
tial receptors (TRP): vanilloid receptors (TRPV1-4) [5], 
heat-activated and melastatin-activated (TRPM8), 
activated by low temperatures [6–8]. Researchers, 
including Noël et al. [9] consider that other ionic 
channels also participate in low-temperature sig-
nal transmission: potassium channels with dual do-
mains TRAAK and TREK1, which are activated by 
hyperpolarization and modulated by cyclic sodium 
and potassium nucleotides HCN1 channels [10]. 
The thermoregulatory processes can be divided into 
three stages: peripheral and cortical perception, cen-
tral integration and autonomous and behavioural 
efferent response, while the information about tem-
perature changes is transmitted inwardly through 
Aδ fibres (cold feeling) and C fibres (heat feeling) 
modulated at the level of the spinal cord and brain 
stem. The heat transfer medium itself is made up 
of two heat transfer mediums: heat loss and heat 
retention. The first is located in the previsual anteri-
or part of the hypothalamus and is responsible for 
reactions that increase heat elimination. The second 
medium is located in the posterior hypothalamus, 
responsible for reactions that reduce loss and at 
the same time increase the body’s heat generation 
[11, 12]. Therefore, thermoreceptors placed in the 
anterior hypothalamus are thermodetectors and 
react mainly to an increase in temperature, which 
determines the expansion of skin vascular and sub-
cutaneous tissue and the intensification of sweat 
secretion. On the other hand, neurons located in the 
posterior hypothalamus do not have the character 
of thermodetectors but are a specific switch station 
for impulses from peripheral thermoreceptors. Their 
stimulation results in the release of chemical ther-
mogenesis [13]. 
effect of hypothermia on the human body
Therapeutic hypothermia shows normalizing ef-
fect on metabolic processes disturbed in ischaemic 
conditions, including improving metabolism and 
maintaining glucose balance in the brain, lowering 
the concentration of lactates formed as a result of 
anaerobic metabolism, reducing the intensity of cel-
lular acidosis, limiting the secretion of free radicals 
in damaged neurons, lowering the production of 
pro-inflammatory cytokines (TNF-α, IL-6), stabiliz-
es the blood-brain barrier and reduces endothelial 
dysfunction preventing ischaemic damage to tissues 
and organs [14–18].
Hypothermia also increases the concentration of 
neurotrophins, including brain-derived neurotrophic 
factor (BDNF), as well as enhances angiogenesis in 
ischaemic areas, reducing also the effect of gluta-
mate and other neurotransmitters, resulting from 
their excessive release in pathological states of the 
central nervous system [19–22]. In the hypothermia 
phase, apoptosis is also reduced, including modula-
tion of MAP (mitogen-activated protein) kinases sig-
nal pathways, inhibition of TNF-α (tumour necrosis 
factor-α) and caspase-induced proapoptotic cellular 
signal pathways, which play an important role in the 
regulation of programmable cell death, as well as 
lowering the level and activity of apoptosis-initiating 
proteins: p53-activator protein of apoptosis genes, 
calpain, cathepsins, granzymes, apoptosis-inducing 
factor (AIF) and C-delta protein kinase, with simul-
taneous increase of antiapoptotic factors: C-epsilon 
protein kinase, Bcl-2 protein and serine-threonine 
kinase Act [23–26].
Studies on the effectiveness of therapeutic 
hypothermia
The first reports on the use of therapeutic hypother-
mia in post-resuscitation care can be found in the 
1958 study by Benson et al. [27]. In this study of 
19 patients, 7 were subjected to therapeutic hypo-
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thermia. No significant neurological disorders were 
reported in this group, and in the case of the con-
trol group without hypothermia only in one of the 
seven patients, no significant neurological deficits 
were observed. The increase in global interest in 
therapeutic hypothermia as a therapeutic method 
dates back to the beginning of the 21st century 
when a large study by Bernard et al. was published. 
[28]. Also, the HACA trial indicated that patients 
who have been successfully resuscitated after cardi-
ac arrest due to ventricular fibrillation, therapeutic 
mild hypothermia increased the rate of a favourable 
neurological outcome and reduced mortality [29].
Bernard’s study included 77 patients who were 
randomly assigned to treatment with hypothermia 
(with the core body temperature reduced to 33°C 
within 2 hours after the return of spontaneous cir-
culation and maintained at that temperature for 
12 hours) or normothermia. 21 of the 43 patients 
treated with hypothermia (49%) survived and had 
a good outcome — as compared with 9 of the 
34 treated with normothermia (26%). This differ-
ence was statistically significant (P = 0.046). In the 
case of Holzer, as in the case of Bernard et al. [28] 
patients in the hypothermia group had a favourable 
neurological outcome, as compared with the nor-
mothermia group.
The Storm et al. study showed that the use of 
therapeutic hypothermia was associated with a sta-
tistically significantly shorter stay in ICU stay and me-
chanical ventilation in survivors after OHCA. [30]. In 
other study Storm et al. [31] indicated that the early 
survival benefit seen with therapeutic hypothermia 
persists after two years. Moreover, neurological out-
come significantly improved after mild hypother-
mia treatment (hypothermia group CPC 1–2 59.8% 
vs. control group CPC 1–2 24.5%).
A study published in the Emergency Medicine 
Journal [32] showed that neurological outcome in 
patients resuscitated from non-VF cardiac arrest 
with hypothermia compared to non-hypothermia 
group (CPC 1–2: 27.59% vs 18.20%, respectively). 
The Nielsen et al. study has introduced a great 
amount of confusion in the use of therapeutic hy-
pothermia [33] comparing two target temperatures 
(33°C or 36°C). In this study in unconscious survivors 
of out-of-hospital cardiac arrest of presumed cardiac 
cause, hypothermia at a targeted temperature of 
33°C did not confer a benefit as compared with 
a temperature of 36°C. However, because of the 
ambiguous conclusions reached, that study is often 
over-interpreted. Nielsen indicates a temperature of 
36°C as normothermia, however, due to the fact 
that RSCA is usually followed by fever, a temperature 
of 36°C can be considered to induce hypothermia.
pATIenT CooLInG MeTHodS
The study of Arrich et al. [34] included 650 patients 
from 19 sites within Europe. 462 of all patients 
(79%) received therapeutic hypothermia, 347 (59%) 
were cooled with an endovascular device, and 
114 (19%) received other cooling methods such 
as ice packs, cooling blankets, and cold fluids. The 
median cooling rate was 1.1 degrees C per hour. An 
important but logical result of studies conducted by 
Arrich et al. was a shorter time to initiate cooling 
from the return of spontaneous circulation in case 
of non-invasive cooling methods [34]. Median time 
from ROSC to initiation of cooling using endovascu-
lar cooling was 150 minutes (IQR; 94–226), and in 
the case of another cooling method — 75 minutes 
(IQR; 26–130). Maze et al. carrying out a retrospec-
tive cohort study on consecutive patients indicated 
that the use of endovascular catheters for induction 
of therapeutic hypothermia was associated with 
a high rate of catheter-related thrombosis [35]. 
In turn, Mooney et al. indicated that simple 
cooling with ice bags initiated soon after an arrest 
can be associated with incrementally improved out-
comes, even if transfer to a specialized therapeutic 
hypothermia (TH) centre is required [36]. Study of 
Sendelbach et al. demonstrated that both the delay 
in initiation of therapeutic hypothermia as well as 
the delay in reaching target temperature signifi-
cantly increased the odds of a poor (Cerebral Per-
formance Category, CPC 3–5) compared to (CPC 1) 
neurological outcome [37]. 
Comparison of the impact of cooling with Cool-
gard (Zoll Medical Corporation, Chelmsford, MA, 
USA) and Surface cooling ArticSun® (Medivance 
Inc., Louisville, CO, USA; Fig. 1 and 2) was taken 
on by the team of Pittl et al. [38]. Using both types 
of cooling devices, comparable survival and neuro-
logical status of patients was achieved, however, 
bleeding complications were more frequently en-
countered by invasive cooling.
Therapeutic hypothermia in the framework of 
resuscitation guidelines 
International Liaison Committee on Resuscitation, 
American Heart Association as well as the European 
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Resuscitation Council for the first time introduced 
therapeutic hypothermia as a therapeutic method 
into post-resuscitation care in 2005. AHA then as-
signed this method to Class IIa and ILCOR and ERC 
to Class I. According to the 2010 guidelines, TTM 
was used in patients with ROSC after out-of-hospital 
sudden cardiac arrest in ventricular fibrillation, and 
the target temperature was 32°C to 34°C and was 
maintained from 12 to 24 hours. 
Current American Heart Association (AHA) and 
European Resuscitation Council (ERC) resuscitation 
guidelines recommend that targeted temperature 
management should be implemented in all adult 
coma patients with return of spontaneous circula-
tion (ROCS) after sudden cardiac arrest. The target 
temperature should be between 32°C and 36°C and 
then maintained for at least 24 hours.
In patients with coma after TTM, fever should be 
actively prevented. 
For patients with out-of-hospital cardiac arrest, 
it is not recommended to routinely cool patients 
in prehospital conditions with a rapid intravenous 
infusion of cold fluids after ROSC. 
ConCLUSIonS
Hypothermia has a wide multidirectional effect 
on the human body, which can be useful in pa-
tients. Most available scientific studies show the 
efficacy and benefits of hypothermia in patients with 
out-of-hospital sudden cardiac arrest, including es-
pecially with ventricular fibrillation. The delay in the 
initiation of therapeutic hypothermia and reaching 
target temperature significantly increased the odds 
of a poor neurological outcome. Current American 
Heart Association (AHA) and European Resuscitation 
Council (ERC) resuscitation guidelines recommend 
that targeted temperature management should be 
implemented in all adult coma patients with re-
turn of spontaneous circulation (ROCS) after sudden 
cardiac arrest. However, the controlled heating of 
the patient after the TTM procedure should not 
be forgotten either. The ERC recommends restoring 
normal body temperature at 0.25–0.5°C/h [1]. After 
heating, it is necessary to prevent temperature in-
creases and fever, which may eliminate the beneficial 
effects of hypothermia by increasing the need for 
oxygen and nutrients in tissues and organs, includ-
ing the central nervous system.
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